Argenx SE
ARGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001697862
No open-market purchases or sales by Argenx SE insiders were filed in the last 90 days; 510 institutions reported holding it in 13F filings for Q2 2026, worth $26.1B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Argenx SE as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 199
- −8 vs. Q4 2021
- Shares held
- 32.2M
- +3.31M (+11.5%) vs. Q4 2021
- Total value
- $10.2B
- +$36.9M (+0.4%) vs. Q4 2021
- New holders
- 28
- 92 more added
- Sold out
- 36
- 52 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 510 | $26.1B |
| Q1 2026 | 478 | $21.1B |
| Q4 2025 | 510 | $25.0B |
| Q3 2025 | 470 | $22.5B |
| Q2 2025 | 439 | $17.7B |
| Q1 2025 | 448 | $19.7B |
| Q4 2024 | 397 | $21.0B |
| Q3 2024 | 358 | $19.0B |
| Q2 2024 | 336 | $14.7B |
| Q1 2024 | 328 | $13.4B |
| Q4 2023 | 346 | $12.5B |
| Q3 2023 | 341 | $15.9B |
| Q2 2023 | 290 | $12.0B |
| Q1 2023 | 272 | $11.6B |
| Q4 2022 | 271 | $11.6B |
| Q3 2022 | 255 | $11.2B |
| Q2 2022 | 232 | $12.4B |
| Q1 2022 | 199 | $10.2B |
| Q4 2021 | 208 | $10.1B |
| Q3 2021 | 182 | $8.57B |
| Q2 2021 | 177 | $8.57B |
| Q1 2021 | 191 | $7.84B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Argenx SE; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Indus Capital Partners, LLC | 0 | $0 | 0.00% | −29,383−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −28,366−100.0% | Sold out |
| Kingdon Capital Management, L.L.C. | 0 | $0 | 0.00% | −27,889−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −18,904−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,101−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −11,471−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −11,163−100.0% | Sold out |
| PointState Capital LP | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −7,529−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −4,667−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −4,500−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −4,371−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −4,291−100.0% | Sold out |
| Rock Creek Group, LP | 0 | $0 | 0.00% | −3,603−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −1,928−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −1,557−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −1,550−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −1,540−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −1,527−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −1,058−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −792−100.0% | Sold out |
| Parkwood LLC | 0 | $0 | 0.00% | −686−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −638−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −578−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −420−100.0% | Sold out |
| Snowden Capital Advisors LLC | 0 | $0 | 0.00% | −337−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −91−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Arlington Partners LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Lee Financial Co | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Asymmetry Capital Management, L.P. | – | – | – | – | Not filed |